A total of 417 patients with COVID-19 and at least one liver function test abnormality was included, with 90 patients (21.5%) classified as having liver injury (ALT/AST>3x normal upper limit and/or GGT/ALP>2x upper limit). This evidence concerns the gene GPT and COVID-19.